CareDx, Inc. CDNA revenue by segment, product and geography
In its fiscal year ending 2025-12-31, CareDx, Inc. reported revenue across 1 business segments; the largest, Reportable Segment, was $380M, 100.0% of the filed sum (+13.8% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Reportable Segment$380M100.0%+13.8% yoy
Members sum to the consolidated $380M for this period.
- Service$274M72.3%+10.1% yoy
- Patient And Digital Solutions$56.9M15.0%+30.5% yoy
- Product$48.4M12.7%+18.6% yoy
Members sum to the consolidated $380M for this period.
- United States$360M94.8%+13.3% yoy
- Outside the United States$19.9M5.2%+23.8% yoy
Members sum to the consolidated $380M for this period.
- Reportable Segment$132M100.0%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.